The board of directors at Boule Diagnostics has today appointed Simonetta Tumbiolo, currently Chief Commercial Officer Diagnostic, as Interim Chief Executive Officer, effective June 1 2026.
As previously communicated, Torben Nielsen will step down from the role of CEO. The appointment of Simonetta Tumbiolo ensures continuity in leadership while the Board conducts a process to appoint a permanent CEO.
Chair statement:
“Simonetta has deep knowledge of the Company and its operations, and the Board has full confidence in her ability to lead the business during this transition,” said Torben Jörgensen, Chairman of the Board at Boule Diagnostics.
Interim CEO statement:
“I am honored to take on the role of Interim CEO and to continue working with our global teams,” said Simonetta. “My priority will be to ensure stability in the business and maintain our strategic direction during this period.”
The Company confirms that its strategy, financial targets, and outlook remain unchanged.